Skip to main content
Earnings Labs
Autolus Therapeutics plc logo

Autolus Therapeutics plc (AUTL)

NASDAQ·Healthcare·Biotechnology

$1.26

-1.17%

Mkt Cap $431.15M

Analyst Ratings

Buy

1

Hold

0

Sell

0

Price Target (4 analysts)

$8.87

Range $7.60 – $11.00

Implied Upside

+604.0%

Consensus $8.87 vs current $1.26